Lilly's EBGLYSS Monotherapy Met Primary And Secondary Endpoints At Week 16 In Its Phase 3B ADtouch Study, Showing Significant And Rapid Improvements In Hand And Foot Skin Clearance, Itch And Pain In Adults And Adolescents With Moderate-To-Severe Hand And Foot Atopic Dermatitis

뉴스 본문을 불러오고 있어요.

Lilly's EBGLYSS Monotherapy Met Primary And Secondary Endpoints At Week 16 In Its Phase 3B ADtouch Study, Showing Significant And Rapid Improvements In Hand And Foot Skin Clearance, Itch And Pain In Adults And Adolescents With Moderate-To-Severe Hand And Foot Atopic Dermatitis | 웨이프 WAPE

Lilly's EBGLYSS Monotherapy Met Primary And Secondary Endpoints At Week 16 In Its Phase 3B ADtouch Study, Showing Significant And Rapid Improvements In Hand And Foot Skin Clearance, Itch And Pain In Adults And Adolescents With Moderate-To-Severe Hand And Foot Atopic Dermatitis

기사 요약

관련 종목

댓글 —